Dexketoprofen + Tramadol Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 25 mg dexketoprofen + 37.5 mg tramadol
Reference Brands: Enantyum(EU)
Category:
Analgesic
Dexketoprofen + Tramadol combines dexketoprofen’s inhibition of COX enzymes, reducing prostaglandin synthesis, with tramadol’s activation of opioid receptors and serotonin/norepinephrine reuptake inhibition. Benefits include effective relief from moderate to severe acute pain, rapid onset, and dual mechanisms for enhanced analgesia, with manageable side effects when used responsibly.
Dexketoprofen + Tramadol tablets is available in Tablets
and strengths such as 25 mg dexketoprofen + 37.5 mg tramadol.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Dexketoprofen + Tramadol tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Dexketoprofen + Tramadol tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Dexketoprofen + Tramadol tablets are approved in the EU for managing moderate to severe acute pain, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, this combination is currently not approved or marketed. In the EU, regulatory approval requires comprehensive clinical data and pharmacovigilance plans. Both regions enforce strict prescribing regulations due to the opioid component. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate seamless market access for dexketoprofen + tramadol formulations, ensuring adherence to European standards for safe, effective analgesic therapy while navigating complex regulatory pathways effectively.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing